Expand NVAX Menu
NVAX MENU

NVAX Latest Press Releases

-- December 4, 2024 --

Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 Million PRNewswire 2:00 AM

-- November 18, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 9:12 PM

-- November 15, 2024 --

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) PRNewswire 7:48 AM

-- November 13, 2024 --

Novavax to Participate in Jefferies London Healthcare Conference PRNewswire 8:00 AM

-- November 12, 2024 --

Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights PRNewswire 8:02 AM

-- November 11, 2024 --

U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PRNewswire 8:30 AM

-- November 10, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 12:00 PM

-- November 4, 2024 --

Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024 PRNewswire 4:30 PM

-- November 2, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 12:00 PM

-- October 29, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Globe Newswire 4:00 PM

-- October 28, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Business Wire 4:00 PM

-- October 27, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm PRNewswire 4:00 PM

-- October 25, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 11:00 AM

-- October 23, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Novavax, Inc. and Encourages Investors to Contact the Firm Globe Newswire 4:00 PM

-- October 20, 2024 --

NVAX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Into Novavax, Inc. and Encourages Investors to Contact the Firm Business Wire 4:00 PM

-- October 17, 2024 --

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novavax, Inc. - NVAX PRNewswire 9:43 PM

-- October 16, 2024 --

Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial PRNewswire 8:14 AM

-- October 9, 2024 --

Novavax's Updated 2024-2025 Nuvaxovid COVID-19 Vaccine Receives Authorization in the EU PRNewswire 7:00 AM

-- September 25, 2024 --

Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development PRNewswire 8:00 AM

-- September 13, 2024 --

Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S. PRNewswire 9:26 AM

-- September 4, 2024 --

Novavax to Participate in Upcoming September Conferences PRNewswire 9:25 AM
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth Globe Newswire 9:15 AM

-- August 30, 2024 --

Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S. PRNewswire 3:46 PM

-- August 8, 2024 --

Novavax Reports Second Quarter 2024 Financial Results and Operational Highlights PRNewswire 8:02 AM

-- August 1, 2024 --

Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024 PRNewswire 9:25 AM